Bad News for CBD
By Jimmy Mengel | May 11, 2019 - Baltimore, MD
There is a CBD shortage.
You know cannabidiol (CBD) as the non-psychoactive cannabinoid found in cannabis that has found use in aiding everything from anxiety to seizures.
Ever since Canada legalized its use for all adults, there has been a severe shortage of product.
Everyone wants it. CBD is showing up in creams and tinctures and pills and drinks. People are even giving it to their pets for their joints.
The FDA is even approving CBD-based drugs.
Forecasts are being adjusted all the time, but the latest numbers say CBD will be worth $22 billion in the next two years. That’s up from next to nothing two years ago.
Only problem: The shortage.
For the past two years I’ve been watching a company I knew could solve this lucrative problem. It can supply metric tons — thousands of pounds — of pharmaceutical-grade CBD to the market.
It’s 100% THC-free. And it can be sold on its own, directly to medical patients. Or it can be used as the active ingredient in edibles and ointments.
And because pharmaceutical CBD is not derived from the cannabis plant, there are no supply constraints...
Any posts are just an opinion and should not be taken as investment advice. Always do your own DD
